Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc Azioni (SRPT) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	4.20% 413.46	396.78	331.82	261.24	253.50
Operating Expenses	1.72% 378.56	372.16	352.66	394.76	391.59
Interest Income/Expense	20.41% 4.166	5.234	5.229	5.224	6.323
Benefits Costs and Expenses	4.38% 372.02	356.41	364.99	275.82	766.21
Costs And Expenses	1.72% 378.56	372.16	352.66	394.76	391.59
Operating Income/Loss	41.75% 34.91	24.62	-20.84	-133.52	-138.09
Nonoperating Income/Loss	58.45% 6.543	15.75	-12.33	118.93	-374.62
Income/Loss From Continuing Operations Before Tax	2.67% 41.45	40.37	-33.17	-14.59	-512.71
Income Tax Expense/Benefit	200.85% 5.329	-5.284	7.763	9.355	4.045
Income/Loss From Continuing Operations After Tax	20.89% 36.12	45.66	-40.94	-23.94	-516.75
Net Income/Loss	20.89% 36.12	45.66	-40.94	-23.94	-516.75
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,381% 93.99	3.789	88.89	88.74	88.19
Diluted Average Shares	2,516% 99.11	3.789	88.89	88.74	88.19
Basic Earnings Per Share	50.00% 0.38	0.76	-0.46	-0.27	-5.86
Diluted Earnings Per Share	51.32% 0.37	0.76	-0.46	-0.27	-5.86
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-